Valiant Organics: Board of Directors of the Company at its meeting held on November 5, 2026, has approved the unaudited…
Valiant Organics (VALIANTORG) filed a disclosure titled "Board of Directors of the Company at its meeting held on November 5, 2026, has approved the unaudited financial results for the quarter and half year ended September 30, 2026.…". The company is valued…
What happened
Valiant Organics (VALIANTORG) filed a disclosure with the exchanges on 5 November 2026 at 07:35 PM titled "Board of Directors of the Company at its meeting held on November 5, 2026, has approved the unaudited financial results for the quarter and half year ended September 30, 2026.…".
Company snapshot
Valiant Organics is a small-cap company, with a market value of about ₹1,177 crore.
The stock last traded at ₹420, against a 52-week range of ₹195–₹505 (16.8% below the high).
Before this filing the shares had moved −12.0% over the month and +44.4% over three months. Average daily turnover over the last 20 sessions was about ₹5.2 crore.
Promoters held 37.87% at the end of Q1 FY27, down 0.02% points from the previous quarter. Foreign institutions owned 0.21% and domestic institutions 0.00%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 204 | 8.2 | 2.93 |
| Q2 FY26 | 157 | 5.7 | 2.02 |
| Q3 FY26 | 159 | 3.6 | 1.3 |
| Q4 FY26 | 218 | 15.7 | 5.61 |
| Q1 FY27 | 232 | 29.1 | 10.44 |
What history shows
This is not the company's first results disclosure: BCEIE has 2 earlier filings of this kind on record since May 2026.
After those filings, the stock fell 0.3% on average the next trading day and was down 4.4% on average after five days (2 filings with price data).
Market-wide, 10,840 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 12 Aug 2026 | Unaudited Financial Results For The Quarter Ended June 30, 2026 | −0.2% | −4.4% |
| 12 Aug 2026 | Board Meeting Outcome for Approval Of The Unaudited Financial… | −0.2% | −4.4% |
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 5 November 2026: Board meeting — Financial Results/Other business matters.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.